BioStrand is a Belgian startup developing a platform to analyze genetic data. Its technology aims to detect analogies and genetic variations to drive innovation in precision medicine, biotechnology and agriculture. The company says the underlying technology was developed over the past seven years. BioStrand was created in February 2019 and is led by CEO Dr Ingrid Brands with Dr Dirk van Hyfte as CTO. The company intends to use recent funds to commercialize its platform. The article does not report revenue or user metrics.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

Jun 2020